Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 931 shares of the company’s stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $105.00, for a total transaction of $97,755.00. Following the completion of the sale, the executive vice president now directly owns 27,531 shares in the company, valued at $2,890,755. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Varian Medical Systems, Inc. (NYSE:VAR) opened at 105.31 on Friday. Varian Medical Systems, Inc. has a 52 week low of $75.20 and a 52 week high of $107.08. The company has a market cap of $9.67 billion, a PE ratio of 34.66 and a beta of 0.58. The company has a 50-day moving average of $101.00 and a 200-day moving average of $95.84.

Varian Medical Systems (NYSE:VAR) last posted its earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.09. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The company had revenue of $662.40 million for the quarter, compared to analyst estimates of $663.86 million. During the same quarter in the previous year, the firm earned $1.00 earnings per share. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. On average, equities analysts expect that Varian Medical Systems, Inc. will post $3.93 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This report was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://theolympiareport.com/2017/09/03/kolleen-t-kennedy-sells-931-shares-of-varian-medical-systems-inc-var-stock.html.

A number of institutional investors have recently bought and sold shares of VAR. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its position in Varian Medical Systems by 0.9% in the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 19,563 shares of the medical equipment provider’s stock valued at $1,783,000 after buying an additional 168 shares during the period. Canada Pension Plan Investment Board raised its position in Varian Medical Systems by 43.4% in the first quarter. Canada Pension Plan Investment Board now owns 221,786 shares of the medical equipment provider’s stock valued at $20,211,000 after buying an additional 67,071 shares during the period. Wells Fargo & Company MN raised its position in Varian Medical Systems by 318.2% in the first quarter. Wells Fargo & Company MN now owns 1,302,180 shares of the medical equipment provider’s stock valued at $118,667,000 after buying an additional 990,791 shares during the period. Rockefeller Financial Services Inc. raised its position in Varian Medical Systems by 2.7% in the first quarter. Rockefeller Financial Services Inc. now owns 3,807 shares of the medical equipment provider’s stock valued at $347,000 after buying an additional 99 shares during the period. Finally, Sumitomo Mitsui Asset Management Company LTD raised its position in Varian Medical Systems by 9.0% in the first quarter. Sumitomo Mitsui Asset Management Company LTD now owns 8,145 shares of the medical equipment provider’s stock valued at $742,000 after buying an additional 674 shares during the period. Institutional investors own 99.63% of the company’s stock.

A number of research firms have recently weighed in on VAR. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $100.00 target price on shares of Varian Medical Systems in a research report on Friday. Zacks Investment Research downgraded shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, July 13th. Robert W. Baird reaffirmed a “neutral” rating and issued a $99.00 target price (up from $89.00) on shares of Varian Medical Systems in a research report on Friday, July 14th. Finally, BidaskClub raised shares of Varian Medical Systems from a “buy” rating to a “strong-buy” rating in a research report on Thursday, July 13th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the stock. Varian Medical Systems currently has a consensus rating of “Hold” and an average price target of $97.39.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.